癌痛患者使用麻醉性镇痛药分析  

Analysis of Anesthetic Analgesics in Cancer Pain

作　　者：张玉秋[1] 林慧珠[1] 石娜[1] 

机构地区：[1]清华大学玉泉医院,北京100049

出　　处：《药物流行病学杂志》2005年第5期293-294,317,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:了解和分析我院癌痛患者使用麻醉性镇痛药情况,为临床合理用药提供参考。方法:以WHO 推荐的DDD和DUI为指标,对我院1998-2002年住院癌症患者使用麻醉性镇痛药的处方进行统计分析和评估。结果:麻醉性镇痛药处方中27．36％用于癌症患者,64．82％为60岁以上的老年患者。硫酸吗啡控释片(美施康定) 用量逐年递增,其余品种的用量呈下降趋势。除芬太尼、美施康定DUI>1外,其他DuI均<l。结论:本院麻醉性镇痛药用于癌痛基本合理,但部分品种的用药剂量偏小。Objective： To investigate and analyze the situation of anesthetic analgesics in the treatment of cancer pain in our hospital so as to provide information for rational use of drugs. Method： Based on the DDD and DUI recommended by WHO, the prescriptions of anesthetic analgesics for cancer pain during the period of 1998-2002 were accounted and analyzed. Result： 27.36% of the prescriptions of anesthetic analgesics were used for patients with cancer pain, 64.82% of whom were above the age of 60. The assumption of morphine controlled-released tablets （ MS CONTIN） increased year after year, and the others showed a dropping tendency. Except MS CONTIN and Fentanyl, DUI of the other anesthetic analgesics were below 1. Conclusion： The use of anesthetic analgesics for cancer pain was rational on the whole, but the dosages of part of the analgesics were rather small.

关 键 词：麻醉性镇痛药 癌痛 DDD DUI 

分 类 号：F407.7[经济管理—产业经济]